- 全部删除
- 您的购物车当前为空
Anti-Phospho-SF3B1 (Thr313) Polyclonal Antibody 是一种 Rabbit 抗体,靶向 Phospho-SF3B1 (Thr313)。Anti-Phospho-SF3B1 (Thr313) Polyclonal Antibody 可用于 WB。
Anti-Phospho-SF3B1 (Thr313) Polyclonal Antibody 是一种 Rabbit 抗体,靶向 Phospho-SF3B1 (Thr313)。Anti-Phospho-SF3B1 (Thr313) Polyclonal Antibody 可用于 WB。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
50 μL | ¥ 1,490 | 5日内发货 | |
100 μL | ¥ 2,245 | 5日内发货 |
产品描述 | Anti-Phospho-SF3B1 (Thr313) Polyclonal Antibody is a Rabbit antibody targeting Phospho-SF3B1 (Thr313). Anti-Phospho-SF3B1 (Thr313) Polyclonal Antibody can be used in WB. |
别名 | SF3B1 (p-Thr313), SF3B1 (p-T313), p-SF3B1 (Thr313), p-SF3B1 (T313) |
Ig Type | IgG |
交叉反应 | Human,Mouse |
应用 | |
推荐剂量 | WB: 1:1000-2000 |
抗体种类 | Polyclonal |
宿主来源 | Rabbit |
构建方式 | Polyclonal Antibody |
纯化方式 | The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen. |
性状 | Liquid |
缓冲液 | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
研究背景 | splicing factor 3b subunit 1(SF3B1) Homo sapiens This gene encodes subunit 1 of the splicing factor 3b protein complex. Splicing factor 3b, together with splicing factor 3a and a 12S RNA unit, forms the U2 small nuclear ribonucleoproteins complex (U2 snRNP). The splicing factor 3b/3a complex binds pre-mRNA upstream of the intron's branch site in a sequence independent manner and may anchor the U2 snRNP to the pre-mRNA. Splicing factor 3b is also a component of the minor U12-type spliceosome. The carboxy-terminal two-thirds of subunit 1 have 22 non-identical, tandem HEAT repeats that form rod-like, helical structures. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008], |
偶联 | Unconjugated |
其他可选修饰符 | Phospho |
免疫原 | A synthesized phosphopeptide: human SF3B1 around the phosphorylation site of Thr313 |
抗原种属 | human |
Uniprot ID |
分子量 | Actual: 145 kDa. |
储存方式 | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
运输方式 | Shipping with blue ice. |
评论内容